Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adverse events account for less than 10% of 1-800 calls on OTCs -- NDMA survey.

This article was originally published in The Tan Sheet

Executive Summary

ADVERSE EVENTS ACCOUNT FOR LESS THAN 10% OF OTC 1-800 CALLS on average, according to a Nonprescription Drug Manufacturers Association survey of 18 member companies. Conducted this fall, the survey involved companies marketing varying types and quantities of OTC product lines. NDMA reported the survey results at its annual Research & Scientific Development Conference held Nov. 12-13 in Washington, D.C. during a workshop entitled: "Listening to the Consumer: The Value of 1-800 Numbers."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086343

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel